TSON Share Price

Open 1.95 Change Price %
High 2.24 1 Day 0.11 5.64
Low 1.95 1 Week 0.00 0.00
Close 2.06 1 Month 0.00 0.00
Volume 143426 1 Year 0.00 0.00
52 Week High 269.34
52 Week Low 141.05
TSON Important Levels
Resistance 2 2.33
Resistance 1 2.22
Pivot 2.08
Support 1 1.90
Support 2 1.79
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

TranS1 Inc. (NASDAQ: TSON)

TSON Technical Analysis 1.5
As on 31st May 2013 TSON Share Price closed @ 2.06 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.48 & Buy for SHORT-TERM with Stoploss of 2.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
TSON Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TSON Other Details
Segment EQ
Market Capital 75824008.00
Sector Health Care Medical/Dental Instruments
Industry
Offical website
TSON Address
TSON
N/A
TSON Latest News
Interactive Technical Analysis Chart TranS1 Inc. ( TSON NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on TranS1 Inc.
TSON Business Profile
Baxano Surgical Inc, formerly TranS1 Inc., is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region. It develops its pre-sacral approach to allow spine surgeons to access and treat intervertebral spaces without compromising important surrounding soft tissue, nerves and bone structures. As of December 31, 2011, the Company was marketing the AxiaLIF family of products for single and multilevel lumbar fusion, the Vectre and Avatar lumbar posterior fixation systems and Bi-Ostetic bone void filler, a biologics product. All of the Company�s AxiaLIF products are delivered using its pre-sacral approach. It generates revenue from the sales of itsimplants and disposable surgical instruments. It has two distinct sales methods.